Advertisement
Advertisement

QLGN

QLGN logo

Qualigen Therapeutics Inc

3.97
USD
-0.07
-1.73%
Dec 20, 15:59 UTC -5
Closed
...

Qualigen Therapeutics Inc Profile

About

Qualigen Therapeutics Inc. is a biotechnology company. It is focused on developing products for the treatment and testing of cancer and infectious diseases. The company's product pipeline consist AS1411 and Gold Nanoparticle ALAN, RAS-F3 and STARS(TM) blood cleansing system, which are in clinical stage. Qualigen Therapeutics Inc., formerly known as Ritter Pharmaceuticals Inc., is based in CA, United States.

Info & Links

CEO

Michael S. Poirier

Headquarters

5857 Owens Avenue, Suite 300
CARLSBAD, CA 92008, UNITED STATES

Industry

Pharmaceuticals Other

Sector

Health Technology

Website

www.qualigeninc.com

Auditor

BAKER TILLY US, LLP

Share holders

287

Employees

4

Qualigen Therapeutics Inc Statistics

Valuation Measures

Market Capitalization2

2.94M

Enterprise Value

3.98M

Enterprise Value/EBITDA(ttm)

-0.63

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

293.34%

Return on Assets(ttm)

-424.18%

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

0.00

Gross Profit(ttm)

0.00

EBITDA(ttm)3

-6.29M

Net Income Available to Common(ttm)

-7.94M

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

-0.70

52-Week Change

-88.67%

S&P 500 52-Week Change

24.21%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

736.43K

Dividend Yield

0.00%

Float4

723.00K

% Held by Insiders

1.80%

% Held by Institutions

3.18%

Balance Sheet

Total Cash(mrq)

1.69M

Total Cash Per Share(mrq)

2.29

Total Debt(mrq)

1.43M

Total Debt/Equity(mrq)

-66.99%

Current Ratio(mrq)

0.52%

Quick Ratio(mrq)

0.52%

Book Value Per Share(mrq)

-3.91

Cash Flow

Operating Cash Flow Per Share(ytd)

-10.46

Free Cash Flow(ytd)

-4.06M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement